< Back to previous page
Project
Pathogenesis and treatment of canine thyroid tumors (CTT)
64 dogs with CTT are included in three clinical trials. Firstly, we will determine the effectiveness of cyclooxygenase-2 inhibitor (Piroxicam) and tyrosine kinase inhibitor (Toceranib Phosphate) in CTT treatment. Secondly, we will determine the best dosage, route and timing of rhTSH (recombinant-human-thyroid-stimulating-hormone) for radioiodine-131 treatment optimization. Thirdly, we will evaluate the effectiveness of rhTSH in the radioiodine-131 treatment of CTT.
Date:1 May 2010 → 28 Feb 2015
Keywords:rhTSH, radioiodine, thyroid, tyrosine kinase inhibitor, cyclooxygenase-2 inhibitor
Disciplines:Endocrinology and metabolic diseases, Other veterinary sciences, Medical imaging and therapy, Veterinary medicine, Animal biology, Other agricultural, veterinary and food sciences